Stockscreener 앱 받기
7.10
6.21%
-0.47
전일 마감가:
$7.57
열려 있는:
$7.61
하루 거래량:
761.68K
Relative Volume:
0.97
시가총액:
$468.96M
수익:
$301.79M
순이익/손실:
$-43.42M
주가수익비율:
-10.59
EPS:
-0.6705
순현금흐름:
$-44.87M
1주 성능:
-8.15%
1개월 성능:
-11.14%
6개월 성능:
+56.73%
1년 성능:
+12.70%
1일 변동 폭
$7.015
$7.61
1주일 범위
$7.015
$7.83
52주 변동 폭
$3.86
$9.31
Evolus Inc Stock (EOLS) Company Profile
명칭
Evolus Inc
전화
(949) 284-4555
주소
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Compare EOLS vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EOLS
Evolus Inc
|
7.10 | 468.96M | 301.79M | -43.42M | -44.87M | -0.6705 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Evolus Inc Stock (EOLS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 다운그레이드 | Needham | Buy → Hold |
| 2025-04-17 | 개시 | BTIG Research | Buy |
| 2024-01-29 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-06-23 | 개시 | Needham | Buy |
| 2022-05-12 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-01-20 | 업그레이드 | Truist | Hold → Buy |
| 2021-05-06 | 업그레이드 | Mizuho | Neutral → Buy |
| 2021-04-08 | 재확인 | H.C. Wainwright | Buy |
| 2021-02-24 | 다운그레이드 | Truist | Buy → Hold |
| 2020-07-07 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2020-02-06 | 재개 | Mizuho | Buy |
| 2019-11-26 | 개시 | SVB Leerink | Outperform |
| 2019-09-05 | 재개 | Mizuho | Buy |
| 2019-06-28 | 개시 | Wells Fargo | Market Perform |
| 2019-06-11 | 개시 | Barclays | Underweight |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-02-14 | 개시 | H.C. Wainwright | Buy |
| 2019-01-29 | 개시 | Stifel | Buy |
모두보기
Evolus Inc 주식(EOLS)의 최신 뉴스
UTMD Trades at a Premium to the Industry: How to Play the Stock? - Zacks Investment Research
(EOLS) Volatility Zones as Tactical Triggers - Stock Traders Daily
Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future - Yahoo Finance
Evolus Insider MOATAZEDI DAVID Sells 105,108 Shares at $9.04 Each (NASDAQ: EOLS) - Kalkine Media
Evolus president & CEO David Moatazedi sells $950,018 in shares By Investing.com - Investing.com South Africa
Evolus president & CEO David Moatazedi sells $950,018 in shares - Investing.com India
Evolus president & CEO David Moatazedi sells $950,018 in shares By Investing.com - Investing.com Nigeria
Evolus president & CEO David Moatazedi sells $950,018 in shares By Investing.com - Investing.com Canada
Evolus president & CEO David Moatazedi sells $950,018 in shares - investing.com
Evolus president & CEO David Moatazedi sells $950,018 in shares - Investing.com
Evolus Officer Sold Shares Worth Over $950K - TradingView
Insider at Evolus (NASDAQ: EOLS) moves to sell nearly $1M in stock - Stock Titan
Evolus (EOLS) Advances 2.36% to $9.09, Holding Ground Above SupportRange Breakout - dars.gov.et
Evolus (EOLS) adds Soleus group as new 5.3% shareholder - Stock Titan
(EOLS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2 - Eastern Progress
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet - Eastern Progress
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet - Yahoo Finance
Evolus (EOLS) Earnings Update: The EPS Result Is Above Expectation in the Current Update; Market Response: Shares Move Higher 2.22% on the DayEarnings Decline Risk - vinanet.vn
Evolus (EOLS) Earnings Update: The EPS Result Is Above Expectation in the Current Update; Market Response: Shares Move Higher 2.22% on the DayRevenue Per Share - dars.gov.et
Evolus (EOLS) Results Check: EPS Prints Above Forecast in the Latest Reading; Trading Move - vinanet.vn
Evolus (EOLS) Results Check: EPS Prints Above Forecast in the Latest Reading; Trading Move - vinanet.vn
EOLS | Evolus, Inc. Common Stock FinancialsRevenue Breakdown - quiverquant.com
Evolus (EOLS) Results Check: EPS Prints Above Forecast in the Latest Reading; Trading Move - dars.gov.et
Evolus (EOLS) Quarter in Focus: EPS Comes in Above Forecast on the Day; Share Move: The Share Price Adds 5.28% in the Current UpdateRevenue Warning Signal - vinanet.vn
Evolus (EOLS) Quarter in Focus: EPS Comes in Above Forecast on the Day; Share Move - dars.gov.et
Evolus (EOLS) Quarter in Focus: EPS Comes in Above Forecast on the Day; Share Move: The Share Price Adds 5.28% in the Current UpdatePretax Income Report - dars.gov.et
Evolus (EOLS) Closing Note: Records a 5.28% Increase to $8.18 in the Latest Session; the Price Remains Bounded by the Supplied Support and Resistance in the Available RecordBearish Sentiment - vinanet.vn
EOLS Q2 2026 Earnings: EPS Turns Positive, Delivering 156.82% Surprise vs. EstimatesCost Structure Review - vinanet.vn
August 2026's Leading Growth Companies With Insider Confidence - Sahm
Renaissance Technologies LLC Lowers Stake in Evolus, Inc. $EOLS - marketbeat.com
Evolus, Inc. (EOLS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Assenagon Asset Management S.A. Grows Stock Holdings in Evolus, Inc. $EOLS - marketbeat.com
EOLS Q2 2026 Earnings: EPS Surprises to the Upside as Shares SlipReturn On Equity - vinanet.vn
Evolus (NASDAQ:EOLS) Reaches New 1-Year HighHere's What Happened - MarketBeat
Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade - Yahoo Finance
Evolus: The Injectable Platform Is Becoming The Real Moat (NASDAQ:EOLS) - Seeking Alpha
Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade - Zacks Investment Research
EOLS Q2 2026 Earnings: EPS of $0.02 Beats Estimates by 156.8% as Profitability Inflection EmergesSpecial Dividend Alert - vinanet.vn
Trading Systems Reacting to (EOLS) Volatility - Stock Traders Daily
Evolus (NASDAQ:EOLS) Rating Increased to Buy at Wall Street Zen - marketbeat.com
Needham Maintains Evolus(EOLS.US) With Hold Rating - moomoo.com
BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13 - Moomoo
Evolus Inc (EOLS) Stock News Today - TradingKey
Evolus, Inc. (EOLS) Investor Outlook: Analyzing 97.93% Potential Upside in the Aesthetic Market - DirectorsTalk Interviews
Evolus (EOLS) Stock Jumps On Margin Turn And EBITDA Momentum - simplywall.st
Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $17 - Moomoo
Evolus, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:EOLS) 2026-08-06 - Seeking Alpha
Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Su - GuruFocus
Earnings call transcript: Evolus tops revenue forecast in Q2 2026, shares rise - Investing.com UK
Evolus Inc (EOLS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Evolus Inc 주식 (EOLS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DAVID MOATAZEDI | Officer |
Sep 02 '26 |
Proposed Sale |
9.04 |
105,108 |
950,019 |
0 |
| Avelar Rui | See Remarks |
Mar 20 '26 |
Sale |
4.75 |
3,119 |
14,815 |
427,423 |
| MOATAZEDI DAVID | See Remarks |
Mar 20 '26 |
Sale |
4.75 |
13,669 |
64,929 |
604,700 |
| MOATAZEDI DAVID | See Remarks |
Mar 17 '26 |
Sale |
4.89 |
116,720 |
570,562 |
618,369 |
| Avelar Rui | See Remarks |
Mar 17 '26 |
Sale |
4.89 |
29,996 |
146,629 |
430,542 |
| Avelar Rui | See Remarks |
Mar 16 '26 |
Option Exercise |
0.00 |
8,804 |
0 |
460,538 |
| MOATAZEDI DAVID | See Remarks |
Mar 16 '26 |
Option Exercise |
0.00 |
67,489 |
0 |
735,089 |
| Avelar Rui | See Remarks |
Dec 22 '25 |
Sale |
7.15 |
2,261 |
16,168 |
356,821 |
| MOATAZEDI DAVID | See Remarks |
Dec 22 '25 |
Sale |
7.15 |
10,539 |
75,361 |
354,388 |
6.90%
자본화:
|
볼륨(24시간):